Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

BNP-guided therapy not better than expert's clinical assessment for beta-blocker titration in patients with heart failure.

Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H.

Congest Heart Fail. 2005 Sep-Oct;11(5):248-53; quiz 254-5.

2.

Optimising the use of beta-blockers in older patients with heart failure.

Owen A.

Drugs Aging. 2002;19(9):671-84. Review.

PMID:
12381236
3.

BNP in hormone-guided treatment of heart failure.

Richards AM, Lainchbury JG, Nicholls MG, Troughton RW, Yandle TG.

Trends Endocrinol Metab. 2002 May-Jun;13(4):151-5. Review.

PMID:
11943558
4.

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts.

Latini R, Masson S, de Angelis N, Anand I.

J Card Fail. 2002 Oct;8(5):288-99. Review.

PMID:
12411979
5.

Ejection fraction improvement by beta-blocker treatment in patients with heart failure: an analysis of studies published in the literature.

van Campen LC, Visser FC, Visser CA.

J Cardiovasc Pharmacol. 1998;32 Suppl 1:S31-5. Review.

PMID:
9731693
6.

B-type natriuretic peptide and its clinical implications in heart failure.

McCullough PA.

Am Heart Hosp J. 2004 Winter;2(1):26-33. Review.

PMID:
15604836
7.

Beta-blockers for heart failure: why, which, when, and where.

Cleland JG.

Med Clin North Am. 2003 Mar;87(2):339-71. Review.

PMID:
12693729
8.
9.

BNP as discharge criteria for heart failure.

Caldwell MA, Howie JN, Dracup K.

J Card Fail. 2003 Oct;9(5):416-22. Review.

PMID:
14583905
10.

Beta blocker treatment in heart failure.

Carson PE.

Prog Cardiovasc Dis. 1999 Jan-Feb;41(4):301-21. Review.

PMID:
10362350
11.

[Beta-adrenergic receptor blockers in the treatment of chronic heart failure].

Mularek-Kubzdela T, Grajek S, Cieśliński A.

Pol Merkur Lekarski. 1996 Aug;1(2):120-3. Review. Polish.

PMID:
9156910
12.

When to initiate beta-blockers in heart failure: is it ever too early?

Fonarow GC.

Curr Heart Fail Rep. 2005 Aug;2(2):94-9. Review.

PMID:
16036057
13.

Surrogate end points in heart failure.

Lee CR, Adams KF Jr, Patterson JH.

Ann Pharmacother. 2002 Mar;36(3):479-88. Review.

PMID:
11895063
14.

Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure.

Saremi A, Gopal D, Maisel AS.

Expert Rev Cardiovasc Ther. 2012 Feb;10(2):191-203. doi: 10.1586/erc.11.188. Review.

PMID:
22292875
15.
16.

The utility of BNP in clinical practice.

Sharp A, Mayet J.

J Renin Angiotensin Aldosterone Syst. 2004 Jun;5(2):53-8. Review.

PMID:
15295715
17.

[Management of patients with Duchenne muscular dystrophy].

Ishihara T.

No To Hattatsu. 2004 Mar;36(2):130-5. Review. Japanese.

PMID:
15031987
18.

Is exercise training beneficial for heart failure patients taking β-adrenergic blockers? A systematic review and meta-analysis.

Ismail H, McFarlane J, Smart NA.

Congest Heart Fail. 2013 Mar-Apr;19(2):61-9. doi: 10.1111/chf.12000. Epub 2012 Sep 9. Review.

19.

Brain natriuretic peptide in the management of heart failure: the versatile neurohormone.

de Denus S, Pharand C, Williamson DR.

Chest. 2004 Feb;125(2):652-68. Review.

PMID:
14769750
20.

β-Blocker therapy in heart failure with preserved ejection fraction: Importance of dose and duration.

Yamamoto K.

J Cardiol. 2015 Sep;66(3):189-94. doi: 10.1016/j.jjcc.2015.02.004. Epub 2015 Apr 13. Review.

PMID:
25881728
Items per page

Supplemental Content

Write to the Help Desk